Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Renal cancer
ADR ID BADD_A03741
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.08      Renal and urinary tract neoplasms malignant and unspecified
16.08.02      Renal neoplasms malignant
16.08.02.001      Renal cancer
20      Renal and urinary disorders
20.01      Renal disorders (excl nephropathies)
20.01.04      Renal neoplasms
20.01.04.002      Renal cancer
Description Tumors or cancers of the KIDNEY. [MeSH]
MedDRA Code 10038389
MeSH ID D007680
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Carcinoma kidney | Kidney cancer | Kidney carcinoma | Malignant neoplasm of kidney, except pelvis | Renal cancer | Renal carcinoma | Malignant neoplasm of kidney, excl pelvis | Malignant renal neoplasm | Kidney Neoplasms | Kidney Neoplasm | Neoplasm, Kidney | Renal Neoplasms | Neoplasm, Renal | Neoplasms, Renal | Renal Neoplasm | Neoplasms, Kidney | Cancer of Kidney | Kidney Cancers | Renal Cancer | Cancer, Renal | Cancers, Renal | Renal Cancers | Cancer of the Kidney | Kidney Cancer | Cancer, Kidney | Cancers, Kidney
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00073Aliskiren0.000609%
BADD_D00193Axitinib0.026695%
BADD_D00330Cabozantinib0.001892%
BADD_D00447Chlorpropamide--
BADD_D00858Everolimus0.001483%
BADD_D00869Famotidine0.000431%
BADD_D01136Imatinib--
BADD_D01245Lansoprazole--
BADD_D01260Leuprolide acetate--
BADD_D01418Methotrexate--
BADD_D01687Pazopanib0.003380%
BADD_D01777Pioglitazone0.000515%
BADD_D01834Prednisone--
BADD_D01913Ranitidine0.026088%
BADD_D01955Rivastigmine0.000542%
BADD_D02058Sorafenib0.001164%
BADD_D02100Sunitinib0.034765%
BADD_D02331Valsartan0.001481%
BADD_D02342Vedolizumab--
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02407Upadacitinib--
BADD_D02412Octreotide--
BADD_D02464Fingolimod--
BADD_D02487Baricitinib--
The 1th Page    1    Total 1 Pages